AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance
April 25, 2025 16:05 ET | Source: AEON Biopharma IRVINE, Calif., April…
AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
February 07, 2025 16:05 ET | Source: AEON Biopharma IRVINE, Calif., Feb.…
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering
January 06, 2025 09:00 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering
January 06, 2025 09:00 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
January 03, 2025 20:02 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
January 03, 2025 20:02 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
January 03, 2025 20:02 ET | Source: AEON Biopharma IRVINE, Calif., Jan.…